The pharmaceutical industry stands at a decisive moment where science, technology, and strategy must converge to unlock true value. As the global market becomes more complex, driven by biologics, ...
SINGAPORE, Aug. 4, 2025 /PRNewswire/ -- Tikva Allocell (Tikva), a biotechnology company developing off-the-shelf CAR-T cell therapies for solid tumors, today announced that its Founder and CEO, Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback